"Rank","NCT Number","Title","Acronym","Status","Study Results","Conditions","Interventions","Outcome Measures","Sponsor/Collaborators","Gender","Age","Phases","Enrollment","Funded Bys","Study Type","Study Designs","Other IDs","Start Date","Primary Completion Date","Completion Date","First Posted","Results First Posted","Last Update Posted","Locations","Study Documents","URL"
1,"NCT03449069","Pediatric MSC-AFP Sub-study for Crohn's Fistula",,"Recruiting","No Results Available","Fistula in Ano|Crohn Disease","Drug: MSC-AFP","Number of participants with treatment-related adverse events (safety and toxicity)|Number of participants with response to the treatment regarding cessation of drainage from the treated fistula.|Number of participants with radiographic response to the treatment regarding the treated fistula.","Mayo Clinic","All","12 Years to 17 Years   (Child)","Phase 1","5","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","17-010539","July 23, 2018","February 28, 2023","February 28, 2023","February 28, 2018",,"March 31, 2022","Mayo Clinic in Rochester, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03449069"
2,"NCT02589119","Stem Cell Fistula Plug in Cryptoglandular Perianal Fistulas (MSC-AFP)",,"Completed","No Results Available","Perianal Fistula|Cryptoglandular Perianal Fistula","Drug: MSC-AFP","Number of participants with treatment-related adverse events (safety and toxicity).|Number of participants with response to the treatment regarding potential cessation of drainage from their fistula.","Mayo Clinic","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 1","15","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","15-003200","January 2016","September 2019","September 2019","October 28, 2015",,"December 6, 2019","Mayo Clinic in Rochester, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT02589119"
3,"NCT03209700","Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas","MSC-AFP","Completed","No Results Available","Perianal Fistula|Cryptoglandular Perianal Fistula|Crohn's Perianal Fistula","Drug: MSC-AFP","Number of participants with treatment-related adverse events (safety and toxicity).|Number of participants with response to the treatment regarding potential cessation of drainage from their fistula.","William A. Faubion, M.D.|Mayo Clinic","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 1","7","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","17-004503","July 20, 2017","December 10, 2019","December 10, 2019","July 6, 2017",,"January 3, 2020","Mayo Clinic in Minnesota, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03209700"
4,"NCT03220243","Stem Cell Coated Fistula Plug in Patients With Crohn's RVF",,"Completed","No Results Available","Fistula Vagina|Crohn Disease","Drug: MSC-AFP","Number of participants with treatment-related adverse events (safety and toxicity).|Number of participants with response to the treatment regarding potential cessation of drainage from their fistula.","Mayo Clinic","Female","18 Years to 65 Years   (Adult, Older Adult)","Phase 1","5","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","17-002892","October 19, 2017","September 20, 2020","September 20, 2020","July 18, 2017",,"October 30, 2020","Mayo Clinic in Rochester, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03220243"
5,"NCT01915927","Stem Cell Fistula Plug in Perianal Crohn's Disease","MSC-AFP","Completed","No Results Available","Perianal Crohn's Disease","Drug: MSC-AFP","To determine the safety and toxicity of using autologous MSC coated fistula plug in patients with fistulizing Crohn's Disease.|To assess in preliminary fashion the response of fistula healing induced by the GORE plug containing MSC","William A. Faubion, M.D.|Mayo Clinic","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 1","20","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","12-009716","July 2013","December 2019","December 2019","August 5, 2013",,"January 3, 2020","Mayo Clinic, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT01915927"
